Literature DB >> 26461171

The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

A DerHovanessian1, S S Weigt1, V Palchevskiy1, M Y Shino1, D M Sayah1, A L Gregson2, P W Noble3, S M Palmer4, M C Fishbein5, B M Kubak2, A Ardehali6, D J Ross1, R Saggar1, J P Lynch1, R M Elashoff7, J A Belperio1.   

Abstract

Primary graft dysfunction (PGD) is a possible risk factor for bronchiolitis obliterans syndrome (BOS) following lung transplantation; however, the mechanism for any such association is poorly understood. Based on the association of TGF-β with acute and chronic inflammatory disorders, we hypothesized that it might play a role in the continuum between PGD and BOS. Thus, the association between PGD and BOS was assessed in a single-center cohort of lung transplant recipients. Bronchoalveolar lavage fluid concentrations of TGF-β and procollagen collected within 24 h of transplantation were compared across the spectrum of PGD, and incorporated into Cox models of BOS. Immunohistochemistry localized expression of TGF-β and its receptor in early lung biopsies posttransplant. We found an association between PGD and BOS in both bilateral and single lung recipients with a hazard ratio of 3.07 (95% CI 1.76-5.38) for the most severe form of PGD. TGF-β and procollagen concentrations were elevated during PGD (p < 0.01), and associated with increased rates of BOS. Expression of TGF-β and its receptor localized to allograft infiltrating mononuclear and stromal cells, and the airway epithelium. These findings validate the association between PGD and the subsequent development of BOS, and suggest that this association may be mediated by receptor/TGF-β biology. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26461171      PMCID: PMC4946573          DOI: 10.1111/ajt.13475

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  48 in total

1.  Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.

Authors:  A Elssner; F Jaumann; S Dobmann; J Behr; M Schwaiblmair; H Reichenspurner; H Fürst; J Briegel; C Vogelmeier
Journal:  Transplantation       Date:  2000-07-27       Impact factor: 4.939

2.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

3.  Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs.

Authors:  Danny Jonigk; Marlene Merk; Kais Hussein; Lavinia Maegel; Katharina Theophile; Michaela Muth; Ulrich Lehmann; Clemens L Bockmeyer; Michael Mengel; Jens Gottlieb; Tobias Welte; Axel Haverich; Heiko Golpon; Hans Kreipe; Florian Laenger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Outcome of lung transplanted patients with primary graft dysfunction.

Authors:  Christopher M Burton; Martin Iversen; Nils Milman; Mikhail Zemtsovski; Jørn Carlsen; Daniel Steinbrüchel; Jann Mortensen; Claus B Andersen
Journal:  Eur J Cardiothorac Surg       Date:  2006-11-28       Impact factor: 4.191

5.  Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.

Authors:  S S Weigt; C A Finlen Copeland; A Derhovanessian; M Y Shino; W A Davis; L D Snyder; A L Gregson; R Saggar; J P Lynch; D J Ross; A Ardehali; R M Elashoff; S M Palmer; J A Belperio
Journal:  Am J Transplant       Date:  2013-02-07       Impact factor: 8.086

6.  Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients.

Authors:  C Martin; L Papazian; M J Payan; P Saux; F Gouin
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

7.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Authors:  E Van Obberghen-Schilling; N S Roche; K C Flanders; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

8.  Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis.

Authors:  Hanni S Alho; Paula K Maasilta; Tiina Vainikka; Ulla-Stina Salminen
Journal:  Exp Lung Res       Date:  2007-08       Impact factor: 2.459

9.  Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group.

Authors:  A Magnan; J L Mege; J C Escallier; J Brisse; C Capo; M Reynaud; P Thomas; B Meric; L Garbe; M Badier; L Viard; P Bongrand; R Giudicelli; D Metras; P Fuentes; D Vervloet; M Noirclerc
Journal:  Am J Respir Crit Care Med       Date:  1996-04       Impact factor: 21.405

10.  Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

Authors:  Deepali Kumar; Dean Erdman; Shaf Keshavjee; Teresa Peret; Raymond Tellier; Denis Hadjiliadis; Grant Johnson; Melissa Ayers; Deborah Siegal; Atul Humar
Journal:  Am J Transplant       Date:  2005-08       Impact factor: 8.086

View more
  15 in total

Review 1.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

2.  TGF-β1 Impairs Vitamin D-Induced and Constitutive Airway Epithelial Host Defense Mechanisms.

Authors:  Jasmijn A Schrumpf; Dennis K Ninaber; Anne M van der Does; Pieter S Hiemstra
Journal:  J Innate Immun       Date:  2019-04-10       Impact factor: 7.349

3.  Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study.

Authors:  Stuart C Sweet; Hyunsook Chin; Carol Conrad; Don Hayes; Peter S Heeger; Albert Faro; Samuel Goldfarb; Ernestina Melicoff-Portillo; Thalachallour Mohanakumar; Jonah Odim; Marc Schecter; Gregory A Storch; Gary Visner; Nikki M Williams; Karen Kesler; Lara Danziger-Isakov
Journal:  Am J Transplant       Date:  2019-07-25       Impact factor: 8.086

Review 4.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

5.  Extracellular histones play a pathogenic role in primary graft dysfunction after human lung transplantation.

Authors:  Yang Jin; Meng Sun; Xin Lv; Xingan Wang; Gening Jiang; Chang Chen; Zongmei Wen
Journal:  RSC Adv       Date:  2020-03-27       Impact factor: 4.036

6.  Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.

Authors:  Mitsuteru Yoshida; Hisashi Oishi; Tereza Martinu; David M Hwang; Hiromitsu Takizawa; Junichi Sugihara; Trevor D McKee; Xiaohui Bai; Zehong Guana; Christina Lua; Hae-Ra Cho; Stephen Juvet; Marcelo Cypel; Shaf Keshavjee; Mingyao Liu
Journal:  Oncotarget       Date:  2018-01-03

7.  Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.

Authors:  M Y Shino; S S Weigt; N Li; A Derhovanessian; D M Sayah; R H Huynh; R Saggar; A L Gregson; A Ardehali; D J Ross; J P Lynch; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2016-10-31       Impact factor: 9.369

Review 8.  [Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].

Authors:  Sijia Yang; Abudumailamu Abuduwufuer; Wang Lv; Feichao Bao; Jian Hu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-06-20

Review 9.  The role of innate immunity in the long-term outcome of lung transplantation.

Authors:  Mitsuaki Kawashima; Stephen C Juvet
Journal:  Ann Transl Med       Date:  2020-03

10.  Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome.

Authors:  Laura Pandolfi; Roberta Fusco; Vanessa Frangipane; Ramona D'Amico; Marco Giustra; Sara Bozzini; Monica Morosini; Maura D'Amato; Emanuela Cova; Giuseppina Ferrario; Patrizia Morbini; Miriam Colombo; Davide Prosperi; Simona Viglio; Davide Piloni; Rosanna Di Paola; Salvatore Cuzzocrea; Federica Meloni
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.